Without NIH, we likely wouldn’t have COVID-19 vaccines yet. We wouldn’t have the sequencers used to identify the disease in the first place. We wouldn't have virtually any of the consequential therapies or diagnostics from the last thirty years.

The National Institutes of Health is where Biotech goes to dream. If Biotech wants to dream bigger, a good place to start is the NIH budget.

Two things to know here. First, we should be spending a lot more on NIH. Second, COVID has made it all-but certain that infectious disease will displace cancer as the best-funded area of life science research.

Read the full post on Medium.